Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Andalusian Agency for Health Technology Assessment (AETSA) published new recommendations for hip arthroplasty in patients with osteoarthritis

AETSA aimed to establish recommendations for clinical practice on hip arthroplasty in patients with osteoarthritis through a systematic appraisal of evidence.

The following recommendations were made:

  • In patients with clinical and radiologic criteria of hip osteoarthritis and who have exhausted all possibilities to control this disease with proper medical treatment conservative, hip surgery will be proposed (based on consensus Group)
  • In patients with advances stages of hip osteoarthritis is proposed as therapeutic option the total hip arthroplasty when the expected revision rate at 10 years is less than or equal to 5 % (based on the recommendations from National Institute for Health and Care Excellence)
  • To reduce the risk of complications after hip arthroplasty the use of given bearing surfaces must be based on clinical and functional needs of each patients, regardless age and gender (weak strength of recommendation)
  • The use of ceramic-ceramic bearing surfaces against metal-polyethylene to reduce osteolisys risk after hip arthroplasty at 10 years is suggested (weak strength of recommendation)
  • To reduce the ostheolisys risk in hip osteoarthritis is propose that this intervention was performed in patients with a BMI ≤ 30 kg/m2 (weak strength of recommendation)

The full document in Spanish is available here.

Subscribe to our biweekly newsletter not to miss important reimbursement information.